Global Genitourinary Drugs market size is predicted to grow from US$ 30670 million in 2025 to US$ 37530 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031. Get Access Now!

Global Genitourinary Drugs Market Size and Outlook 2025-31

The global Genitourinary Drugs market size is predicted to grow from US$ 30670 million in 2025 to US$ 37530 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. United States market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Genitourinary Drugs is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Genitourinary Drugs players cover Novartis AG, Genentech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Genitourinary Drugs Industry Forecast looks at past sales and reviews total world Genitourinary Drugs sales in 2024, providing a comprehensive analysis by region and market sector of projected Genitourinary Drugs sales for 2025 through 2031. With Genitourinary Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genitourinary Drugs industry. This Insight Report provides a comprehensive analysis of the global Genitourinary Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genitourinary Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Genitourinary Drugs market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genitourinary Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genitourinary Drugs. This report presents a comprehensive overview, market shares, and growth opportunities of Genitourinary Drugs market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Urologicals &nbsp;&nbsp;&nbsp; Hormonal Therapy &nbsp;&nbsp;&nbsp; Gynecological &nbsp;&nbsp;&nbsp; Anti-infectives Segmentation by Application: &nbsp;&nbsp;&nbsp; Prostate Cancer &nbsp;&nbsp;&nbsp; Ovarian Cancer &nbsp;&nbsp;&nbsp; Bladder Cancer &nbsp;&nbsp;&nbsp; Cervical Cancer &nbsp;&nbsp;&nbsp; Renal Cancer &nbsp;&nbsp;&nbsp; Erectile Dysfunction &nbsp;&nbsp;&nbsp; Urinary Tract Infections &nbsp;&nbsp;&nbsp; Urinary Incontinence & Overactive Bladder &nbsp;&nbsp;&nbsp; Sexually Transmitted Diseases This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Novartis AG &nbsp;&nbsp;&nbsp; Genentech Key Questions Addressed in this Report What is the 10-year outlook for the global Genitourinary Drugs market? What factors are driving Genitourinary Drugs market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Genitourinary Drugs market opportunities vary by end market size? How does Genitourinary Drugs break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Genitourinary Drugs Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Genitourinary Drugs by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Genitourinary Drugs by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Genitourinary Drugs Segment by Type &nbsp;2.2.1 Urologicals &nbsp;2.2.2 Hormonal Therapy &nbsp;2.2.3 Gynecological &nbsp;2.2.4 Anti-infectives &nbsp;2.3 Genitourinary Drugs Sales by Type &nbsp;2.3.1 Global Genitourinary Drugs Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Genitourinary Drugs Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Genitourinary Drugs Sale Price by Type (2020-2025) &nbsp;2.4 Genitourinary Drugs Segment by Application &nbsp;2.4.1 Prostate Cancer &nbsp;2.4.2 Ovarian Cancer &nbsp;2.4.3 Bladder Cancer &nbsp;2.4.4 Cervical Cancer &nbsp;2.4.5 Renal Cancer &nbsp;2.4.6 Erectile Dysfunction &nbsp;2.4.7 Urinary Tract Infections &nbsp;2.4.8 Urinary Incontinence & Overactive Bladder &nbsp;2.4.9 Sexually Transmitted Diseases &nbsp;2.5 Genitourinary Drugs Sales by Application &nbsp;2.5.1 Global Genitourinary Drugs Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Genitourinary Drugs Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Genitourinary Drugs Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Genitourinary Drugs Breakdown Data by Company &nbsp;3.1.1 Global Genitourinary Drugs Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Genitourinary Drugs Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Genitourinary Drugs Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Genitourinary Drugs Revenue by Company (2020-2025) &nbsp;3.2.2 Global Genitourinary Drugs Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Genitourinary Drugs Sale Price by Company &nbsp;3.4 Key Manufacturers Genitourinary Drugs Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Genitourinary Drugs Product Location Distribution &nbsp;3.4.2 Players Genitourinary Drugs Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Genitourinary Drugs by Geographic Region &nbsp;4.1 World Historic Genitourinary Drugs Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Genitourinary Drugs Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Genitourinary Drugs Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Genitourinary Drugs Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Genitourinary Drugs Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Genitourinary Drugs Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Genitourinary Drugs Sales Growth &nbsp;4.4 APAC Genitourinary Drugs Sales Growth &nbsp;4.5 Europe Genitourinary Drugs Sales Growth &nbsp;4.6 Middle East & Africa Genitourinary Drugs Sales Growth 5 Americas &nbsp;5.1 Americas Genitourinary Drugs Sales by Country &nbsp;5.1.1 Americas Genitourinary Drugs Sales by Country (2020-2025) &nbsp;5.1.2 Americas Genitourinary Drugs Revenue by Country (2020-2025) &nbsp;5.2 Americas Genitourinary Drugs Sales by Type (2020-2025) &nbsp;5.3 Americas Genitourinary Drugs Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Genitourinary Drugs Sales by Region &nbsp;6.1.1 APAC Genitourinary Drugs Sales by Region (2020-2025) &nbsp;6.1.2 APAC Genitourinary Drugs Revenue by Region (2020-2025) &nbsp;6.2 APAC Genitourinary Drugs Sales by Type (2020-2025) &nbsp;6.3 APAC Genitourinary Drugs Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Genitourinary Drugs by Country &nbsp;7.1.1 Europe Genitourinary Drugs Sales by Country (2020-2025) &nbsp;7.1.2 Europe Genitourinary Drugs Revenue by Country (2020-2025) &nbsp;7.2 Europe Genitourinary Drugs Sales by Type (2020-2025) &nbsp;7.3 Europe Genitourinary Drugs Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Genitourinary Drugs by Country &nbsp;8.1.1 Middle East & Africa Genitourinary Drugs Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Genitourinary Drugs Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Genitourinary Drugs Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Genitourinary Drugs Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Genitourinary Drugs &nbsp;10.3 Manufacturing Process Analysis of Genitourinary Drugs &nbsp;10.4 Industry Chain Structure of Genitourinary Drugs 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Genitourinary Drugs Distributors &nbsp;11.3 Genitourinary Drugs Customer 12 World Forecast Review for Genitourinary Drugs by Geographic Region &nbsp;12.1 Global Genitourinary Drugs Market Size Forecast by Region &nbsp;12.1.1 Global Genitourinary Drugs Forecast by Region (2026-2031) &nbsp;12.1.2 Global Genitourinary Drugs Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Genitourinary Drugs Forecast by Type (2026-2031) &nbsp;12.7 Global Genitourinary Drugs Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Novartis AG &nbsp;13.1.1 Novartis AG Company Information &nbsp;13.1.2 Novartis AG Genitourinary Drugs Product Portfolios and Specifications &nbsp;13.1.3 Novartis AG Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Novartis AG Main Business Overview &nbsp;13.1.5 Novartis AG Latest Developments &nbsp;13.2 Genentech &nbsp;13.2.1 Genentech Company Information &nbsp;13.2.2 Genentech Genitourinary Drugs Product Portfolios and Specifications &nbsp;13.2.3 Genentech Genitourinary Drugs Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Genentech Main Business Overview &nbsp;13.2.5 Genentech Latest Developments 14 Research Findings and Conclusion

Report	Global Genitourinary Drugs Market Growth 2025-2031
Selected License	Multi ID: LPI22945

Buyer Information

Order Summary